Filings
| Filing | Date | Type | Filed with |
|---|
| Presentation Material for Financial Results Summary for the First Half of the Fiscal Year Ending March 31, 2027 | Oct 29, 2026 | Results | Tokyo Stock Exchange |
|---|
| Consolidated Financial Results for the Six Months Ended September 30, 2026 (Under Japanese GAAP) | Oct 29, 2026 | Results | Tokyo Stock Exchange |
|---|
| Notice Regarding Decision to Pursue the Sale of or Exit from the Medical Platform Business | Oct 29, 2026 | Acquisition or disposal | Tokyo Stock Exchange |
|---|
| Notice Regarding the Establishment of a Subsidiary through a Company Split and the Transfer of Shares in the Subsidiary (Change in Subsidiary) | Oct 21, 2026 | Other filings | Tokyo Stock Exchange |
|---|
| Notice Regarding the Transfer of the Data Health Business to Medcare, Inc. through a Company Split (Simplified Absorption-Type Company Split) | Oct 21, 2026 | Acquisition or disposal | Tokyo Stock Exchange |
|---|
| Presentation Material for Financial Results Summary for the First Quarter of the Fiscal Year Ending March 31, 2027 | Jul 29, 2026 | Results | Tokyo Stock Exchange |
|---|
| Summary of the Results of the Evaluation of the Effectiveness of the Board of Directors | Jul 22, 2026 | Results | Tokyo Stock Exchange |
|---|